Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer
Clinical trial NCT05900921 · UNKNOWN
Trial details
- NCT number
- NCT05900921
- Sponsor
- Sichuan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2024-10-31
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.